Archive for 2010

Delta & Comair make 90 minute trip in 20 hours

I recently had the pleasure of experiencing Delta and Comair‘s friendly customer support as I attempted to make the 90 minute trip from Minneapolis to Toronto on DL 6350. A series of mechanical failures on Delta/Comair‘s aircraft resulted in me arriving at my destination seventeen hours late. After the first flight was canceled due to […]


For success in biotechnology, look beyond biotechnology

Many biotechnology entrepreneurs favorably look back at times when financing and regulatory approval were easier to obtain. While future periods of investor exuberance may return, it is better to see these as market aberrations. In periods of investor exuberance companies have been pushed to focus on low-probability, high-return, objectives such as approval and successful marketing […]


Building an R&D cluster in Okinawa

The public portion of the International Symposium Development of an R&D Cluster in Okinawa has been posted. The symposium brought experts from around the world, with a particular emphasis on regions such as San Diego, Singapore, and Israel. Complete coverage, including video links in English and Japanese are on the Okinawa Institute for Science and […]


Technology Continues to Fight Aids

This is a guest post from BiotechBlog reader Jack Lundee Technology Continues to Fight Aids In 2008, Sub-Saharan Africa was populated with over 22 million HIV+ inhabitants, and currently there are over 5 million Southern Africans infected with the virus. Worldwide, there are upwards of 40 million people infected with HIV, a very frightening number. […]


Drug Patent Expirations in December 2010

Drug Patent Expirations in December 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CHILDREN’S MOTRIN Mcneil Cons ibuprofen 5,215,755*PED Dec 1, 2010 JUNIOR STRENGTH MOTRIN Mcneil Cons ibuprofen 5,215,755*PED Dec 1, 2010 MOTRIN Mcneil Ped ibuprofen 5,215,755*PED Dec 1, 2010 ZYFLO CR Cornerstone Therap zileuton 4,873,259 Dec […]


Patent Expirations Will Stabilize the Pharmaceutical Industry

“Patent Expirations Will Stabilize the Pharmaceutical Industry.” I must believe it, because I’m quoted in the St. Louis Observer as having said it! The reporter did a good job of capturing what I meant, quoting me as saying “the industry will be more diverse, with a more stable, though smaller, revenue base spread among many […]


Journal of Commercial Biotechnology — November 2010 issue now available

The November 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 4 Editorial For success in biotechnology, look beyond biotechnology PDF Yali Friedman Commentary Federal bureaucrats slip on oil spill PDF Henry I Miller Articles R&D spending and […]


Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration SAMSCA Otsuka America Pharm tolvaptan 5,258,510 Nov 2, 2010 TRUVADA Gilead emtricitabine; tenofovir disoproxil fumarate 5,210,085*PED Nov 11, 2010 COZAAR Merck losartan potassium 5,210,079*PED Nov 11, 2010 EMTRIVA Gilead emtricitabine 5,210,085*PED Nov 11, 2010 […]


Globalization in the pharmaceutical industry: Where are drugs invented?

I’ve just had a paper published in Nature Reviews Drug Discovery, using data from DrugPatentWatch to profile the locations of drugĀ invention for the past decade. The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) and […]